Beginning with the July 7, 2021 launch of the Kuali IRB system, use of the forms on these pages will be gradually phased out. The process will be complete by the end of July 2022.
Please note the following:
The forms on these pages will only be used for transactions in the legacy e-IRB Services system.
This matrix breaks down when to use each system during the
Forms for submitting new projects for IRB review will be removed by July 6, 2021. Starting July 7, all applications for new studies must be done in Kuali IRB and these forms will
not be accepted for upload into Kuali IRB.
Amendment, Report and Closure forms will continue to be available on these pages only for use with projects already active in e-IRB Services. These forms should only be used until
those projects either close or roll over into Kuali IRB at their next Continuing Review.
Continuing Review forms will continue to be available on these pages only for use with projects that will expire before August 30, 2021 or that will be complete by July 31, 2022.
Research involving an IND exemption
— required for research requesting an IND exemption for the use of a drug, bioavailability or
bioequivalence studies, studies involving radioactive or cold isotopes, or foods including dietary
supplements and conventional/medical foods (released 1/28/2014)